PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 19, 2026Advanced Optical Materials0 citations

High‐Sensitivity Label‐Free Biosensing Enabled by a Fabrication‐Tolerant Dual‐Ribbon Quasi‐BIC Metasurface

View Full Paper
YLYunfeng LiELEdurne LópezJPJavier Plou

Key Points

  • This research aims to develop a robust dual-ribbon metasurface for high-sensitivity optical biosensing without the need for angle tuning.
  • Developed a dual-ribbon metal-insulator-metal metasurface hosting quasi-BIC resonances.
  • Conducted numerical simulations and experimental validations.
  • Integrated the metasurface into a microfluidic chip for real-time biosensing.
  • Monitored anti-insulin antibodies and refractive index variations in HeLa cell supernatants.
  • Achieved a refractive index sensitivity exceeding 400 nm.
  • Surface sensitivity measured at 0.065 nm with a detection limit of 1.71 nM.
  • Demonstrated label-free monitoring of cell viability changes through resonance shifts.

Abstract

ABSTRACT Plasmonic metasurfaces that host bound states in the continuum (BICs) enable high sensitivity optical biosensing, yet most implementations rely on angle resolved excitation or deliberate symmetry breaking. Here, we present a dual‐ribbon metal‐insulator‐metal metasurface that hosts robust quasi‐BIC (qBIC) resonances at normal incidence without angular tuning. By combining numerical simulations and experiments, we have identified a highly sensitive qBIC mode with a strong analyte overlap, a refractive index sensitivity of more than 400 nm , and robustness to fabrication tolerances. Integrated into a microfluidic chip, this metasurface enables real‐time, stepwise immunoassay monitoring of anti‐insulin antibodies under continuous flow (surface sensitivity 0.065 nm ; estimated limit of detection (LOD) 1.71 nM) and demonstrates label‐free monitoring of refractive index variations in UV‐stressed HeLa cell supernatants, with resonance shifts consistent with changes in cell viability. The alignment‐free, robust platform provides a practical route toward high‐performance, label‐free biosensing.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Li et al. (2026) studied this question.

synapsesocial.com/papers/6996a8c7ecb39a600b3efdb1https://doi.org/10.1002/adom.202503577
Ask AI
Helpful
Bookmark
Share
View Full Paper